Related references
Note: Only part of the references are listed.Prevalence of pretreatment HIV drug resistance in key populations: a systematic review and meta-analysis
Virginia Macdonald et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2020)
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa
Stefanie Kroeze et al.
AIDS (2018)
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
Seth C. Inzaule et al.
SCIENTIFIC REPORTS (2018)
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa
Andrew N. Phillips et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia
Alula M. Teklu et al.
BMC HEALTH SERVICES RESEARCH (2017)
Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort
Simbarashe Takuva et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
Raph L. Hamers et al.
LANCET INFECTIOUS DISEASES (2012)
Share Paper
